← Open Payments lookup

MASON BEEL: Open Payments

NPI 1932748910 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$822 in 46 payments from 19 companies in 2025. Trend: 2023 $1,219 · 2024 $1,159 · 2025 $822

Food & beverage: $822
CompanyPaymentsAmount
ABBVIE INC.14$217
Astellas Pharma US Inc2$67
Actelion Pharmaceuticals US, Inc.3$62
AstraZeneca Pharmaceuticals LP4$61
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$43
Takeda Pharmaceuticals U.S.A., Inc.2$38
Axsome Therapeutics, Inc.2$37
Otsuka America Pharmaceutical, Inc.2$32
Lundbeck LLC2$32
Amneal Pharmaceuticals LLC2$32

Products named: UBRELVY, QULIPTA, Veozah, REXULTI, OPSUMIT, AIRSUPRA, CAPLYTA, TRINTELLIX.

Industry payments across NE — which companies pay providers there.